Correlation Between Bone Biologics and Bluejay Diagnostics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bone Biologics and Bluejay Diagnostics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bone Biologics and Bluejay Diagnostics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bone Biologics Corp and Bluejay Diagnostics, you can compare the effects of market volatilities on Bone Biologics and Bluejay Diagnostics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bone Biologics with a short position of Bluejay Diagnostics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bone Biologics and Bluejay Diagnostics.

Diversification Opportunities for Bone Biologics and Bluejay Diagnostics

0.13
  Correlation Coefficient

Average diversification

The 3 months correlation between Bone and Bluejay is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding Bone Biologics Corp and Bluejay Diagnostics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bluejay Diagnostics and Bone Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bone Biologics Corp are associated (or correlated) with Bluejay Diagnostics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bluejay Diagnostics has no effect on the direction of Bone Biologics i.e., Bone Biologics and Bluejay Diagnostics go up and down completely randomly.

Pair Corralation between Bone Biologics and Bluejay Diagnostics

Given the investment horizon of 90 days Bone Biologics Corp is expected to under-perform the Bluejay Diagnostics. But the stock apears to be less risky and, when comparing its historical volatility, Bone Biologics Corp is 3.41 times less risky than Bluejay Diagnostics. The stock trades about -0.16 of its potential returns per unit of risk. The Bluejay Diagnostics is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  530.00  in Bluejay Diagnostics on August 28, 2024 and sell it today you would lose (155.00) from holding Bluejay Diagnostics or give up 29.25% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Bone Biologics Corp  vs.  Bluejay Diagnostics

 Performance 
       Timeline  
Bone Biologics Corp 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Bone Biologics Corp are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak essential indicators, Bone Biologics reported solid returns over the last few months and may actually be approaching a breakup point.
Bluejay Diagnostics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bluejay Diagnostics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's fundamental indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Bone Biologics and Bluejay Diagnostics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bone Biologics and Bluejay Diagnostics

The main advantage of trading using opposite Bone Biologics and Bluejay Diagnostics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bone Biologics position performs unexpectedly, Bluejay Diagnostics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bluejay Diagnostics will offset losses from the drop in Bluejay Diagnostics' long position.
The idea behind Bone Biologics Corp and Bluejay Diagnostics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Other Complementary Tools

Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.